Dr. Alexander Meritt Quattlebaum, MD

Dr. Quattlebaum practices at Novant Health Forsyth Medical Center in Winston Salem, North Carolina, part of Novant Health.

Dr. Quattlebaum's NPI, 1578128419, was assigned on May 7, 2019. Dr. Quattlebaum graduated from University of South Florida College of Medicine in 2019. Dr. Quattlebaum holds North Carolina license 2022-01029.

Dr. Quattlebaum's primary practice is Novant Health Forsyth Medical Center, at 3333 Silas Creek Parkway, Winston Salem, NC 27103 in Forsyth County. The practice phone is (336) 718-5000.

Dr. Quattlebaum's primary practice is Novant Health Forsyth Medical Center in Winston Salem, North Carolina, part of Novant Health. Dr. Quattlebaum is also affiliated with Atrium Health Wake Forest Baptist Medical Center. The medical group on file is Novant Health Indian Land Primary Care. Dmand AI also links Dr. Quattlebaum to 1 more hospital outpatient department and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Quattlebaum practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Quattlebaum's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Quattlebaum is licensed in North Carolina.

CMS data shows 136 Medicare services from Dr. Quattlebaum across 2 procedure codes in 2024, for 146 Medicare patients. Medicare paid $14,466 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 146 Medicare patients who saw Dr. Quattlebaum in 2024. The largest group is 65 to 74, with 45 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 29% are also on Medicaid. Their average risk score is 3.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Quattlebaum's median patient age at 74, with 56% women.

In 2024, Dr. Quattlebaum wrote 25 Medicare Part D claims for 11 patients. 88% of them were for generic drugs. They cover 13 drugs, with $8,630 in total drug cost. In 2021, CMS named 424 claims across 19 drugs.

Dr. Quattlebaum accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Quattlebaum, published from 2024 to 2025. 2025 was the busiest year, with 2. The most frequent topics are Immune Checkpoint Inhibitors, Drug-Related Side Effects and Adverse Reactions and Immunotherapy. Dr. Quattlebaum has published most often in Immunotherapy. Dr. Quattlebaum's most frequent co-authors are Andrew Thomas Faucheux, MD, Thomas William Lycan, DO and Heidi D. Klepin, MD.

CMS Open Payments shows 10 general payments to Dr. Quattlebaum from 8 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 68% of the total. Genentech, Inc. paid the most, $186.

Dr. Quattlebaum graduated from University of South Florida College of Medicine in 2019.